Sterling Biotech Ltd

A Delhi court on Monday declared four directors of a Gujarat-based pharma firm, Sterling Biotech Ltd (SBL), "fugitive economic offenders" in a Rs 8,100-crore bank fraud case.

Sterling Biotech Ltd has informed BSE that the 25th Annual General Meeting (AGM) of the Company was held on June 30, 2011.

Sterling Biotech Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from June 23, 2011 to June 30, 2011 (both days inclusive) for the purpose of Payment of Dividend & 25th Annual General Meeting (AGM) of the Company to be held on June 30, 2011.

Sterling Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 31, 2011, inter alia, has recommended 50% [Rs. 0.50 per equity share of F.V. of Re. 1/- each] dividend on the equity shares for the financial year ended December 31, 2010 subject to approval of the members at the ensuing Annual General Meetin...

Sterling Biotech Ltd has informed BSE that the Company had issued FCCB of USD 175 million in September 2005. Of these bonds:  1. FCCB with Nominal Value of USD 135.46 million are converted in to Equity Shares adding Rs. 593.61 Crs to net worth of the Company.  2. FCCB with Nominal Value of USD 39.54 million (equivalent to Rs. 208.13 crs)h...

A Delhi court on Monday declared four directors of a Gujarat-based pharma firm, Sterling Biotech Ltd (SBL), "fugitive economic offenders" in a Rs 8,100-crore bank fraud case.

Sterling Biotech Ltd has informed BSE that the 25th Annual General Meeting (AGM) of the Company was held on June 30, 2011.

Sterling Biotech Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from June 23, 2011 to June 30, 2011 (both days inclusive) for the purpose of Payment of Dividend & 25th Annual General Meeting (AGM) of the Company to be held on June 30, 2011.

Sterling Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 31, 2011, inter alia, has recommended 50% [Rs. 0.50 per equity share of F.V. of Re. 1/- each] dividend on the equity shares for the financial year ended December 31, 2010 subject to approval of the members at the ensuing Annual General Meetin...

Sterling Biotech Ltd has informed BSE that the Company had issued FCCB of USD 175 million in September 2005. Of these bonds:  1. FCCB with Nominal Value of USD 135.46 million are converted in to Equity Shares adding Rs. 593.61 Crs to net worth of the Company.  2. FCCB with Nominal Value of USD 39.54 million (equivalent to Rs. 208.13 crs)h...